ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001002.1|Jawsamycin_1 # 1 # 1053 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=GGC;rbs_spacer=13bp;gc_cont=0.687	BGC0001002.1|Jawsamycin_1 	1	1053	-	Loose	400	25.7942	ArnT	42.86	3005053	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGAAAGGGGACCGAATGTCCAAGCGCGCGCTGATCACCGGAATCACCGGGCAGGACGGCTCGTACCTCGCCGAGCATCTGCTCGCCGAGGGCTATCAGGTGTGGGGGCTGACCCGAGGGCAGGCCAACCCGCGCAAAGACCGGGTGGCCAAGCTGATACCCGACCTCGCGTTCGTGGACGGTGACTTGATGGACCAGGGGAGCCTGGTCTCGGCTGTGGACCTGGTGCAGCCGGACGAGGTGTACAACCTGGGGGCCGTCTCCTTCGTGCCCATGTCCTGGCAGCAGCCCGAGCTCGTCACCGAAGTCAACGGCACCGGGGTGCTGCGCATGCTCGAAGCGATCCGGATGGTGAGCGGGCTGGGCAAGTCCACGGGCGGGAGCGACGGCCACGGCCAGATCCGCTTCTACCAGGCATCCTCCTCGGAGATGTTCGGGAAGGTGGTGGAGTCGCCGCAGAGCGAGCAGACCCCCTTCCACCCGCGCAGCCCCTACGGGGTGGCCAAGGCCTACGGCCACTACATCACCCAGAACTACCGGGAGTCCTACGGGGTGTTCGGGGTCTCGGGCATCCTCTTCAACCACGAATCCCCCCGCCGCGGAGCGGAGTTCGTGACCCGGAAGATCTCCCTCGCCGTGGCGCAGATCAAGCTGGGCCTCCAGGACAAGCTGCTCCTCGGCAACCTGGACGCGGTGCGCGACTGGGGCTTCGCGGGGGACTACGTCCGTGCGATGCACCTGATGCTGCAACAGGACAAGGCCAGGGACTACGTGGTGGGCACGGGCCGGATGCACTCGGTGCGGGACGCCGCGCGCATCGCCTTCGAGGCCGCGGACCTGGACTGGGAGGAGCACGTCGTGGTCGACCCGGCGCTGGTGCGGCCCGCCGAGGTCGAGACGCTGTGCGCCGACTACGGCGACGCCCGCCGGGAGCTGGGCTGGGAGCCGGAGACCGGCTTCGTGGAACTGATGCGGATGATGGTGGAGTCCGACCTCCGCCAGGCCGGCCTCGAGCGTGACCACGGCGAGCTGCTCGCCGGGGCGAGCTGGTAG	MKGDRMSKRALITGITGQDGSYLAEHLLAEGYQVWGLTRGQANPRKDRVAKLIPDLAFVDGDLMDQGSLVSAVDLVQPDEVYNLGAVSFVPMSWQQPELVTEVNGTGVLRMLEAIRMVSGLGKSTGGSDGHGQIRFYQASSSEMFGKVVESPQSEQTPFHPRSPYGVAKAYGHYITQNYRESYGVFGVSGILFNHESPRRGAEFVTRKISLAVAQIKLGLQDKLLLGNLDAVRDWGFAGDYVRAMHLMLQQDKARDYVVGTGRMHSVRDAARIAFEAADLDWEEHVVVDPALVRPAEVETLCADYGDARRELGWEPETGFVELMRMMVESDLRQAGLERDHGELLAGASW	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSLIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAVQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ	63.52	gnl|BL_ORD_ID|2783|hsp_num:0	3795			1554	1638	colistin A; colistin B
BGC0001002.1|Jawsamycin_2 # 1272 # 1601 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGC;rbs_spacer=13bp;gc_cont=0.694	BGC0001002.1|Jawsamycin_2 	1272	1601	+	Loose	200	29.261	BRP(MBL)	25.22	3001205	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic inactivation	Bleomycin resistant protein	GTGCCCAATGTCCGGTCGGAGGCCGCGCAGGAGAGCCGGGAGTTCTACGGCCTGCTGGGCTTCGAAGAGGTCATGAACCACGGCTGGGTCATGACGCTCGCCTCGCCGTCCAGTCCGGCGGCGCAGGTCAGCTTCATGGCCGGCGACAAGACCGCGCCGGTCGTCCCCGACATGAGTGTCGAGGTGGACGACGTGGACGCGGCCTATGCGGCCGTGCGGGACAGCGGCGCGGAGATCGTTCACCCCCTCCAGGACGAGGAGTGGGGCGTGCGGCGGTTCTTCGTCCGCGATCCCAATGGCCGGGTGGTCAACGTGCTGGGCCACCGCTGA	MPNVRSEAAQESREFYGLLGFEEVMNHGWVMTLASPSSPAAQVSFMAGDKTAPVVPDMSVEVDDVDAAYAAVRDSGAEIVHPLQDEEWGVRRFFVRDPNGRVVNVLGHR	MADHVTPNLPSRDFDVTEAFYAKLGFATSWKDRGWMILQRGGLQLEFFPYPDLDPATSSFGCCLRLDDLDAMVALVNAAGAEEKSTGWPRFKAPQLEASGLRIGYLIDPDCTLVRLIQNPD	90.08	gnl|BL_ORD_ID|2356|hsp_num:0	255			18	351	bleomycin; bleomycinic acid; bleomycin A2; bleomycin B2
BGC0001002.1|Jawsamycin_3 # 1630 # 2886 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.727	BGC0001002.1|Jawsamycin_3 	1630	2886	-	Loose	1150	29.6462	tetB(46)	34.38	3004033	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGATCCCTAGTCAGCGCAGGCCGGCAGGCGAGTCGCCGGCCGGCCGGGTGTGCCTGGTCACCGGCGGAACTGCGGGCCTCGGCCGGTCTCTGGCCCGGGCCCTGGCCGACGCCGGGGCCCGCGTGCACGTGGGCGACCACTCCGCGCCCGGTCCGGAGCGCAGCCCCAGTGACCCCGAGCGGGCACCCCAGGACACGTCGATCACGTTCACCGATGTCGATGTGACCGACCGCGCCGCCCTCGAAGCGTGGATCGCCGCCGTCCACGCCGAGCACGGGCGGATCGACGTCCTGATCCACAACGCCGTCCGCATGCATGGCGCTGCTGACGCCGAGGGGATGACCGTCGAGCAGGCGCAGTCGGCCATGCGCGCGGGGTACGACGCGCTGGTCTGCTCGGTGCGGGCGGTGCTGCCGCTGATGCGCTCTGCCGGCGGAGGGCAGATCGTGGCGGTGGGGCCGGGGGAGGGGCGGATGTCCGGCGAGGGCGCTGCCGCTTCCTGCGCCGCGGTGAAGGCGGCCGTCGAGGCGTACACCGAGATGCTGCGGAGCGAACTGGCCGGATCAGGATCCGGCATAGGCGTGACCCTGGTGCGGACGGGCACGGCCGGCAACGGCTTCCGGATGCCCCGTATCGCCGACTTCCTTCCGCCCGCCTCACCGGAGGAGGCCGCGGATGCCGTCGTCCACGCGATCCGGCACCGCCGTCCGTCCGTCGACGTACCCGGCTCCCTGACCCTGTTCCACCGGGGCTTCAAGGTCGCTGCGGCCGGCGTGGCGAAGTGCGAGGGCCTCGCGCTGCGGGCCATCAAGAAGGCCGATGCGAACACCTACTTCCTGCGCGCCATGTCCACCATCGCACCGAGCGTCGACCGCGCCGCCCACCGCTTGACCGGCGGCCGGGTGCTCGTCATGCCCGCCTTGCTGCCGTCCCTGATGCTCACCACGACCGGCAGCGTCAGCGGCCGGCCCCGCCAGGTTCCGCTGCTGTGCCACCCCGAAGCCGACGGCAGCTACCTCATCGTCGCCAGCAACTCGGGCAAACCCCACCACCCCGCGTGGTCCCGGAACCTCCTCACCACCCCCCAGGCGGCCATCACGCGCTTCGGGCGCACCGTCAAGGTGACCGCCACCCTCCTCGACGGTTCCGAGCGAACCGCCGCATGGGACCACATGGTGAAGTTCTGGCCCCCGTACGAGGGTTACGCCCGCAGTTCCGGCCGCAACCTGCGGATCTTCCGCCTGGCCCCCGCCTGA	MIPSQRRPAGESPAGRVCLVTGGTAGLGRSLARALADAGARVHVGDHSAPGPERSPSDPERAPQDTSITFTDVDVTDRAALEAWIAAVHAEHGRIDVLIHNAVRMHGAADAEGMTVEQAQSAMRAGYDALVCSVRAVLPLMRSAGGGQIVAVGPGEGRMSGEGAAASCAAVKAAVEAYTEMLRSELAGSGSGIGVTLVRTGTAGNGFRMPRIADFLPPASPEEAADAVVHAIRHRRPSVDVPGSLTLFHRGFKVAAAGVAKCEGLALRAIKKADANTYFLRAMSTIAPSVDRAAHRLTGGRVLVMPALLPSLMLTTTGSVSGRPRQVPLLCHPEADGSYLIVASNSGKPHHPAWSRNLLTTPQAAITRFGRTVKVTATLLDGSERTAAWDHMVKFWPPYEGYARSSGRNLRIFRLAPA	MKVLKRLLSRITLYPTVFLAGFICLLLATIFSELSPFLLQKMIDGPLTALTHGGGQGDLLQMGGFYLLVLSLGQLISYMGNRILLHGSNQVTASLRDQAFQVMQGLPISYFDDKPAGKIATRIVNDTETLRTQFYNSCMILVIYLVRFLFILGILFYLSPMMGLLLCLVFPIFYGIQYLYKVMTDQPMKDFFDARSEVNTQVNELLHGASMIQLYHQEPGVVEEFEATTQKMLGANDRILLADSIASWTLTELLKFLVIAGILTIAGISFLQGNIGVTAGFLFININYVINLFDLMANLSRQFPNIRRSLETGSRVLAFLDQPLEADGALELKIEKAEVVFDDVQFAYEEGKPVLKDISIQAHPGQTLALVGHTGSGKSSIMNLLYRFYDPQEGEIRIDGQNIRHFSRESLRSHMGIVLQDPYLFTGTIASNVAMSQEHIDRNAVKDALKKVGAWPFVERLEKGIDHPVVEKGSAFSSGERQLISFARTLYMNPQILILDEATSHIDTETEEIIQKAMAVLQKGRTTFIIAHRLSTIQDADQILVLSEGRIVERGQHADLVAHGGIYAQMQAIQQTVE	72.32	gnl|BL_ORD_ID|2309|hsp_num:0	2644			1122	1218	tetracycline
BGC0001002.1|Jawsamycin_4 # 2936 # 3727 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGC;rbs_spacer=13bp;gc_cont=0.689	BGC0001002.1|Jawsamycin_4 	2936	3727	-	Loose	275	24.6386	AAC(6')-Ia	48.0	3002545	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGGATTTCCGAGGCACTATCGGGTCGCGACCGGTCCGGGTGAGGACGCGGTGGTCAGCGGAGGGAGACACAGTGACCGGAGACCAGGTGACCGGAGGCACGGCGGCCCGCGACGTGGAAGCGTCCGAGGATTTCGACGAGATCGCCGACATCCTGACCGACGCGTTCCGCGACACCCCGGTGACCAGCTGGATGGTCCCGCACGGGCTCCCGCAGCGGGAGCGGTACATCACGGGCTTCATGCACGCCTGGGTACGCTTCATGGTCCAGCACGAGGGAACCGCCCTCATCTCGCCCGACCGGGACGCCGTCGTGGTCTGGGAACCGTCCGAGCGCGCCGCCCCTCTCACCGCCGAGGAGCACGAGGCATTCCGCGCCGACATCGTCGCCGCGACCGGTCCCGTAGCCGAACGCTGCCTCACGCTCATGGACCTGGTCGACGCGCACTATCCCCCTGACCTGCCGCCCCACATCCACGGCGCGCTGGCCGCCGTCCGGCCCGGAACCACGAACCGGGGAGCCTTTCTCAGCCTCGCGGTCGCCACGCTGAAGCACATTCATCCCCGGGGGCTGGGCGTCTACTGCGAGGGCACCTCGGAGACGAGCACTGCCTTGTGGGAGCGGCTGGGAGCCAAGCCGATCGGCCCGAAGATCCGGGTCCCGCAGAGCGACATCGCACTCACACCGCTGTTCATCCACCCGGACGACATCGCCCGTCACCCGGCGGTGTCCATGCTCCTGTCCGCTCCGACGACTCCGACAACTTCGACGACTTCGACGACCGGGACATAG	MDFRGTIGSRPVRVRTRWSAEGDTVTGDQVTGGTAARDVEASEDFDEIADILTDAFRDTPVTSWMVPHGLPQRERYITGFMHAWVRFMVQHEGTALISPDRDAVVVWEPSERAAPLTAEEHEAFRADIVAATGPVAERCLTLMDLVDAHYPPDLPPHIHGALAAVRPGTTNRGAFLSLAVATLKHIHPRGLGVYCEGTSETSTALWERLGAKPIGPKIRVPQSDIALTPLFIHPDDIARHPAVSMLLSAPTTPTTSTTSTTGT	MNYQIVNIAECSNYQLEAANILTEAFNDLGNNSWPDMTSATKEVKECIESPNLCFGLLINNSLVGWIGLRPMYKETWELHPLVVRPDYQNKGIGKILLKELENRAREQGIIGIALGTDDEYYRTSLSLITITEDNIFDSIKNIKNINKHPYEFYQKNGYYIVGIIPNANGKNKPDIWMWKSLIKE	142.16	gnl|BL_ORD_ID|522|hsp_num:0	574			27	102	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0001002.1|Jawsamycin_6 # 3907 # 4179 # -1 # ID=1_6;partial=00;start_type=TTG;rbs_motif=GGC;rbs_spacer=14bp;gc_cont=0.641	BGC0001002.1|Jawsamycin_6 	3907	4179	-	Loose	550	22.7126	APH(2'')-Ig	27.91	3002669	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	TTGTCCCGAGGAATGGTGATGGGCCTGCGCGGCCATCCTGGTTTCCCTGGTTTCCCTGGCTTCCTGAGCTACAGCCTCATAGTCAGCGTGAGTATGCAGCCGTCGCGCCGGAACGGACAGGGCGCAGCCGTACCGGAACCCCGGCGCCCTGCATGCGACCTCTTCGGATGGATGCGCTGCCACCTGCGGGAACCCGCGTGCCTCCTCGGTGCATCCCTCAACTATCCCACGGTGAAACGGTCTTCCCGGTCTTCCCGGTATTCCGGAGGATGA	MSRGMVMGLRGHPGFPGFPGFLSYSLIVSVSMQPSRRNGQGAAVPEPRRPACDLFGWMRCHLREPACLLGASLNYPTVKRSSRSSRYSGG	MCEFSSPQIPITDIENAMERIGSPVRELRRLDAGDDSEVLLCNGLFVIKIPKRPSVRVTQQREFAVYSFLKQYDLPALIPEVIFQCSEFNVMSFIPGENFGFQEYALLSEKEKEALASDMAIFLRRLHGISVPLSEKPFCEIFEDKRKRYLEDQEQLLEVLENRKLLNAPLQKNIQTIYEHIGQNQELFNYAACLVHNDFSSSNMVFRHNRLYGVIDFGDVIVGDPDNDFLCLLDCSMDDFGKDFGRKVLRHYGHRNPQLAERKAEINDAYWPIQQVLLGVQREDRSLFCKGYRELLAIDPDAFIL	29.41	gnl|BL_ORD_ID|831|hsp_num:0	903			300	429	amikacin; kanamycin A; tobramycin; gentamicin A; gentamicin
BGC0001002.1|Jawsamycin_9 # 9693 # 11018 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=CTG;rbs_spacer=13bp;gc_cont=0.672	BGC0001002.1|Jawsamycin_9 	9693	11018	+	Loose	400	27.335	QnrD1	30.56	3002788	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GTGCCCATGGACGAGATCACCGAGGACCGCCGCCGGCTGCAAAAAGACGGCCGTCAGGCGGGCGTCTACCTCTACATCGGCGTCCCGTACTGCATCAAGACGACCCCCGGAAAGTGCGGGTACTGCCTGTTCCCGGTGGAGGAGTTCCGGGGCAACGACGCACTGGAGGACTACTACGGGTACGTCGAACGCGAGGCGGAGCTCTACCGGGAACGCTGGGAGGGCTCCGTCCTCACCACGGCGTACTTCGGCGGAGGCACCTCGAACCTGTACCGGCCGCACATGTACCACAAGATCATGGACCTGGTCCGGAGCTTCTTCCCGGACATCTCACCGGCCGCCGACGTGACGCTCGAAGGCATCCCCCAGCTGTTCACCCGGGACAAGATGCAGGCGATCCGCGACTCCGGGATGAACCGGATCAGCATGGGCGTGCAGCAGGTCAACGAACGGCTCAACAGTCTGAGCGGGCGCAAGCAGACCACCCGGCACGTCGTCCAGAGCCTGGAATGGGCACGTGAATTCGGCCTGGCGGCCAATGTGGACGTGATCTTCGGCTGGCCCCGGCAGACCGTGGAGACCATGCTGGAGGACCTGGAGACCCTGGTCTCCTGGGAGGTCCACGACATCACCCACTACGAGCTGAACGTGGGCGGCCCGACCGACTTCGCGCTCAACCGCTTCCACGAACTCCCCAGCACCCTGAGCAACCTGGAGATGTACCGGGAGGCGCGCGACTTCCTCCTCGACCGGGGGTACGAGCAGCACGGGGCCTACAGCTTCCGCAAGCCCGGCGACCCCACCACACGTCTCTTCCGCGAGGGCTACCGCCCGGAGACCACCAGGGACACCTCCGACGCCGTCGGCCTGGGGTACGCCGCGGTCTCCTTCTTCGGCGACGCCTCGCTCGGTGACGGCCGCTCCTGGTCCTTCATCAACCAGCGCAACCTGGCGCTGTACAAGAAGGCGATCGACGAGGGACGGTTCCCCATCGAGCGGGGTTTCCGGCACCAGCCCGCGGACTGGCTCCTGGCCACGCTCTTCCGCAAGCTGCTCAGCATGGAGATCGACCGGGCCGGAATCCGCCGGGCCATGAACGTCGACGTGTACGAGGAGTTCGCCACGATCTGGGACGCGCTGGCCGAGCGCGACCTCGCGGAGATCGAGCCGGACCGGATCAGGCTCGTCGGCGACGGCCCGTTCTACACGCCGCTGGTCTCCGCGCTGCTGGCCGAGGAGCGCTACCGCGCCCTCCGCGAGCGGGAGGCCCACGCCAAGAAGGCCGGACTGGTGCTGGTCGACGACGAAGGAGCGGAGCATGGCTGA	MPMDEITEDRRRLQKDGRQAGVYLYIGVPYCIKTTPGKCGYCLFPVEEFRGNDALEDYYGYVEREAELYRERWEGSVLTTAYFGGGTSNLYRPHMYHKIMDLVRSFFPDISPAADVTLEGIPQLFTRDKMQAIRDSGMNRISMGVQQVNERLNSLSGRKQTTRHVVQSLEWAREFGLAANVDVIFGWPRQTVETMLEDLETLVSWEVHDITHYELNVGGPTDFALNRFHELPSTLSNLEMYREARDFLLDRGYEQHGAYSFRKPGDPTTRLFREGYRPETTRDTSDAVGLGYAAVSFFGDASLGDGRSWSFINQRNLALYKKAIDEGRFPIERGFRHQPADWLLATLFRKLLSMEIDRAGIRRAMNVDVYEEFATIWDALAERDLAEIEPDRIRLVGDGPFYTPLVSALLAEERYRALREREAHAKKAGLVLVDDEGAEHG	MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKLDGEQALQLVESLGVIVHR	206.07	gnl|BL_ORD_ID|758|hsp_num:0	822			351	459	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0001002.1|Jawsamycin_10 # 11011 # 11775 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GAC;rbs_spacer=13bp;gc_cont=0.684	BGC0001002.1|Jawsamycin_10 	11011	11775	+	Loose	400	24.6386	Erm(K)	36.11	3004643	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGCTGACGCCCTTCCACTGAGCGGCCGGAAGTGCGTCGTGACCGGCGGCTCGCGCGGCATCGGCGCCGCGGTAGTGCGGATGGTGCTGGCACAGGGCGCCGACGTGGCCTTCGGCTACCACCACAGCTCCGACCGGGCGGAAGCGCTCCGCGACGAACTGCGCACCGCCTACCCCGAGCAGCGGTGCACGGCGCTGCCGGGCGAGGTGTCCGACGGCGCGGGGGCGGAGAAGTTCGCGGCCGAGGCGCTGAAGTCCCTGGGCGGAGGCCTGGACGTCCTGGTCAACAACGCCGGCATCACCCGGGACATCAGCTTCGCCCGGATGCGCCGGGAGCAGTGGGACGAGGTGATCGACACCAACCTCGGCAGCATGTTCAACGTCACCAGGCCGCTCGTGATGCCGCTGGTGAAGCAGCGGAACGGAACCGTCATCAACATCACCTCCGCCTCCGGCATCCACGGCGCACCCGGCCAGACGGCCTATTCGGCCTCCAAATCCGGGATCATCGGCTTCACGAAGGCACTGGCGAAGGAGGTCGGCGGCCTCGGCGTCACCGTCAACGCCGTCGCTCCCGGGTTCATCCACACGGATATGACGGCCGCGATCCCCGAGCAGCACGCCGACCGCCTGAAATCGATGATCCCCACCCAGGAGTTCGGCTCGGCCGACGACGTCGCGGCACTGGTGTGCTTTCTCGCCTCGGACCGCGCGCGCTACATCACCGGTCAGGTGATCGAAATATCCGGAGGACTTGTCCTGTGA	MADALPLSGRKCVVTGGSRGIGAAVVRMVLAQGADVAFGYHHSSDRAEALRDELRTAYPEQRCTALPGEVSDGAGAEKFAAEALKSLGGGLDVLVNNAGITRDISFARMRREQWDEVIDTNLGSMFNVTRPLVMPLVKQRNGTVINITSASGIHGAPGQTAYSASKSGIIGFTKALAKEVGGLGVTVNAVAPGFIHTDMTAAIPEQHADRLKSMIPTQEFGSADDVAALVCFLASDRARYITGQVIEISGGLVL	MTKKKHKYSNKKLSRGEPPNFSGQHLMHNKKLLQEIVDQAKVSKKDTVLELGAGKGALTTFLSERAKRVLAVEYDQTFIQVLNRKMAHAANTTIIHEDIMRIHLPKGEFVVVSNIPYSITTPIMKKLLSNPVSGFQRGVIVMEKGAAKRFTSPFIKNAYVLAWRMWFDLEYVKGISRECFSPPPKVDSAMVFISRKPDPIVPYKDRSAFFGLAEYALREPKAPADSLLRGIFTATQLKHVKRNAGIKHDVSIGALSERQWGVIFETMTQYVRRPLWPRPRKTTL	89.44	gnl|BL_ORD_ID|2122|hsp_num:0	3341			726	825	erythromycin
BGC0001002.1|Jawsamycin_11 # 11732 # 14041 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GAC;rbs_spacer=15bp;gc_cont=0.708	BGC0001002.1|Jawsamycin_11 	11732	14041	-	Loose	525	30.8018	EVM-1	36.21	3006886	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	EVM beta-lactamase	GTGCGCACCCACGCTGATGTCGCGGCTTCAGCGTCGATTCCTCACCTTGCGCTGTCCGCTCTTGCGGACCGCGGTCACCACGTGGTCGACGAGCCGTTCCTCTTCCCCGCTGCTCAGGCACGCGGGCGGTGCGAGCATGACCGTGCCGCCCTGCTGCCGCGTGTACGCCCCGAGGTCGTACACCGTCTGCTGGACGTTCCCGGCGGTGTCGGCGCTGTCCAGCTCGACGCTCACCGCGAGCCCCTGCCCGCGAACGTCGAGCACACCGTCCGCGCCCCGCAGCTCCCGGCCGAGCACGCTCAGCAGCCTGGCGCCGATGTCGCGAGCCTCGGAAACGGCCCCGGTCGCGCGCATGTGCTCCAGCGTCGCGCTCGCCGCCGCGCAGGCCGCGGGCGAGGCCGACATCGTGTGCCCGTAGGACACGATGCTCCCGGAGGGAAGCCGTTCGAGCACCCCGTTGTCCACCGCGACCGCGGACAGCGCGCACACGCCGTTGGTCAAACCCTTGCTGAAGGCCGTCAGGTCAGGGCGTACGCCCTCGTGCTCGTGCGCGAACCACGCCCCGGTCCTGCCGAGGCCGGTGAACACCTCGTCCAGCACCAGCAGCGCCCCGTACTCGTCGCAGATCCGGCGGATGTCACCGAGCAGCCCTTCGGGCAGCCGGATGCCGCCACCGACGTTCAGGAGCGGCTCGACGAGCACCGTGCCCGCGTGCGAATCCGCCAGGATCGCCCGCAGCTGCCCGGCGATGTGCCGGCGCGCCTGCTGCGACCGCAGCCCCTCGCCGGTGAACTCGCCGAACGTCAGGTGATGGACGCCCGCCCCGCACCGGTCCGGTGTGCTGCTGGTCTGCGGCAGGCCGGACAGCGACTGGCACAGCGCGGTGGAGCCGTGGTAGCCGCGCTCGAAGGTGACGATGTCCTGCCGCCGGCTGCCGGCGGCAGGGCCGGCCGCGGCCCAGTACAGCGACGCGATCTTGACGGCGAGTTCGACCGCCTCCGAACCGCTGTTGGCGAAGAAGAACCGCTCGCCGTCGCGTCGCCGGGCGGCCCGCAGCCGGTCCGCCAGCAGGTGCGCGGGCCGGGCGAGTCCCTGGGACATGTCGATGTGAGCCAGTTCCCGCAGCTGCGACAGGTAGGCGTCCAGGACCGGCTCCACGCCGTGACCGCAGAGCACGTTCAGCGCGCCCGATGTCGCGTCGATCACCCGGTGCCCGCCGCTGTCGACCAGCCACGAGCCTCGTCCGGATACGAACACCGGGCCGGAGTGGTCGTGGGGCGCCCGCCAGGGACGCCCGAGAGCCGAAGCCGCCCCTTCCGTCCCTTCCTTGGAATCCCTGGAATCCATCGTCGCCCAGCTCCTCTTCTCGAACCATGCCCACGGGTCGAAGGGAGCGTGCTCCCCTCATGGAGTGATCTCCGGTCATGGAGTGAGCTCCGGCGCGTTGATGTGCAGGCTGCGCAGGAGCAGACGCGGGTGCCTGGGGTCGTCGGTGAAGTCCTCCCTGGAGTGGGCCAGCACGTCGTTGCGGAAGATCAGGCACTCGCCCGCCCGGAGCAGCAGATCGACGCGGACGTCCGGGTCGGCCCGGCGGTCCCTGAAGTACCGCAGTGCGCGATCGAGCGCCGCCCGTTCCGCCGCGTCCCCCGGATACCAGTGCTCGACCTGTCCCTCGCCGTACCGGGTGGCGTAGTTGCCGTCCCCCAGGCCGGCGAACACGGGCCCGACAGCCTCGCGTTCCACGCCGGGCAGCGTCGAGCGTCTGCCGAGGATCGTGCCCCGCAGCAGGACGTCGGCCGCCTCGGGATCCTCCGTCCGCAGCTCGCCGAATACGCGTCCGGTGTTGAGCAGCGACGTCCTGCCGCCCCGGCGTGCCGGGGACACGCAGTACAGCAGGGTCGTCCTGATGGTCCCGATGTCCTCAAGGAGCCCGTCCGTATGCCAGCCCTGTGCCGCGCACGTGTGGAAGACCGGATGGTCCGAGTCCCCCTTCCGGGTCACCTCGGTGACGCTCGGGGCGTCCCGGTCGCGGTAGAGCAGCGGGACGTAGGGCTCCCCGAGACCGAAGTCGGCGCGGATCGTGCCCATTTCCCGGTGGGCTTCCGCCTTCGACACGGTCGTCAAGGGGCTCCGCGTCACCGCGAAGCCGAACGTCTCCAGCACGTCCAGCGTCTCACCGGGCTTCAGCAGATCGGTCACGTATCCGCGGCCGGGCGGGGTGAGCTCCGCGTAACTCGACTTCGTCAGTTGCATGCCTCGTGCCCAGTCACAGGACAAGTCCTCCGGATATTTCGATCACCTGACCGGTGA	MRTHADVAASASIPHLALSALADRGHHVVDEPFLFPAAQARGRCEHDRAALLPRVRPEVVHRLLDVPGGVGAVQLDAHREPLPANVEHTVRAPQLPAEHAQQPGADVASLGNGPGRAHVLQRRARRRAGRGRGRHRVPVGHDAPGGKPFEHPVVHRDRGQRAHAVGQTLAEGRQVRAYALVLVREPRPGPAEAGEHLVQHQQRPVLVADPADVTEQPFGQPDAATDVQERLDEHRARVRIRQDRPQLPGDVPARLLRPQPLAGELAERQVMDARPAPVRCAAGLRQAGQRLAQRGGAVVAALEGDDVLPPAAGGRAGRGPVQRRDLDGEFDRLRTAVGEEEPLAVASPGGPQPVRQQVRGPGESLGHVDVSQFPQLRQVGVQDRLHAVTAEHVQRARCRVDHPVPAAVDQPRASSGYEHRAGVVVGRPPGTPESRSRPFRPFLGIPGIHRRPAPLLEPCPRVEGSVLPSWSDLRSWSELRRVDVQAAQEQTRVPGVVGEVLPGVGQHVVAEDQALARPEQQIDADVRVGPAVPEVPQCAIERRPFRRVPRIPVLDLSLAVPGGVVAVPQAGEHGPDSLAFHAGQRRASAEDRAPQQDVGRLGILRPQLAEYASGVEQRRPAAPACRGHAVQQGRPDGPDVLKEPVRMPALCRARVEDRMVRVPLPGHLGDARGVPVAVEQRDVGLPETEVGADRAHFPVGFRLRHGRQGAPRHREAERLQHVQRLTGLQQIGHVSAAGRGELRVTRLRQLHASCPVTGQVLRIFRSPDR	MSVKFLVPIAFALSGCAVLPPPIQTPEPLPPAEEVQPEQWAATCEPWDDWDKPAPPYRIFGSTYYVGTCGISAILIAGDDGHILIDSGTEEGAEVVMDNIQKLGFRLNEIASILHSHEHFDHVGGLAKLRAATGAHIVSSAEAAKVLSTGEDHPEDPQFGVHEPMEPVQVDVIVEDGDTVRTETATVTAHATPGHSPGALSWTWVSCSLPGEPPACSRIAYVDSLSAVSSDDYRFTDHPEVVAAFRTSIDKVRSLPCDILLTPHPSSSQLIERLRTGTLGAPGKCATYAAQLGDKLDERLAKENP	252.13	gnl|BL_ORD_ID|3531|hsp_num:0	4600			735	897	
BGC0001002.1|Jawsamycin_12 # 14025 # 14261 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.654	BGC0001002.1|Jawsamycin_12 	14025	14261	-	Loose	900	22.3274	lin	30.95	3004651	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	GTGGACTGTGAATGGGGTACCGCCTCGTGCCCGGCGGCGTTCAGGCTTTTGACGACCTGCGACCCGATGAGCCCGGTACCGCCGATGACCGCGAATTTCATGACACGCCTTCCGCAGGTGCGGGCGTCTGGTCAGTGGCCGACTGGAGCGGTCGGCCGCAATAGGGTTATAGCAGGCCCTCGATTCCGCACGTCCGGAACCGGACACCTACGTGTCGGACGTGCGCACCCACGCTGA	MDCEWGTASCPAAFRLLTTCDPMSPVPPMTANFMTRLPQVRASGQWPTGAVGRNRVIAGPRFRTSGTGHLRVGRAHPR	MSTIEINQLKIEVADRVLVEIPHLLVSKKARIGIIGQNGLGKTTLMEVIAGAKEATSGTVTTQGKLAYIKQLSTDTSTKSGGEKTRKATQHAMRQNPSVLLADEPTSNLDVESVKHLERQWSDFHGALIIISHDRAFLDALCTEIWEIKNQKIHVYKGNYHAYLEQKQQQENQAELAYKEFKNKKKQLQASQTHHEIEAGRIVKPGKRLNNKEASAFKAGKGTQQKKQHSTIKALEKRIERLGNVEKPHTTKPIKIITPDNRVIKKGNTILSAKETAYEIAGRKLFETKAFSIKAGDKVALIGENASGKTTFLKEIIQENPNLLCNPQAKIAYFDQELNGLNQTKSLLENISEISVQTKQVNREVLGSMHFKESDLHKEVRMLSGGERVKLLLSMLLLSDANFLILDEPTNYLDIYAMEALETLIKQFAGTVLFVSHDRTFVNHVAEQLLVIENNEMNFHRMTFAEYEESKAPSRITEEDKLILEMRMSEIAAKLMQPNLKPTEKAILEQDYQEIITKRQQFS	14.91	gnl|BL_ORD_ID|2202|hsp_num:0	3361			51	177	lincomycin
BGC0001002.1|Jawsamycin_13 # 14251 # 15873 # -1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0001002.1|Jawsamycin_13 	14251	15873	-	Loose	500	27.335	fexA	47.37	3002704	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCTGACCGCGGAACCCGGCATCCTGTCGACGATAGGCGCGACGCCCCTGGTCGAACTCGTCAGGCTCTTCCCGGACAGCCCCATCCGCGTGTTCGCCAAGCTCGAAGGGTTCAACCCGGCGGGTAGCATCAAGGACCGGCCCGCCCTGAGCATGCTGGAGGACCGCATCCGCCGCGGCGACCTCGTGCCCGGCGAGTCGGTGGTCGTGGAGTCCAGCTCCGGCAACCTCGGCATCGGCCTCGCACAGGTCTGCCGTTACTACGGCCTACGGTTCATCTGCGTCGTCGACCCCAGGGCCAACAAGCAGAACATCGACATCATGCGCGCCCTCGGCGCCGAGGTGGAGATGGTGACCGAACCCGACCGGGAGACCGGCGACTACCTCCCCGCCCGCGTGGCCCGCGTACGCGAGCTGGCCCGGACCGTCCCCGGCGCCTACTGGCCCGACCAGTACGGCAACACCCTCAACGCCCTCGCGCACCGGACCACGATGCGGGAGATCCACGAGGCGCTGCCCGGCGGCCTGGACTACCTGATCTGCTCGGCGAGCTCCTGCGGCACCCTCCGCGGGTGCGCGGAGTACATCCGCGCGCACCGGCTGCCCGTGAAGATCGTGGCCGTGGACGCGCTGGGCAGCGCCATCTTCGACCCCAGCCCGCCCGCGGTCCCCCGGCTCCTGCCCGGGCACGGGGCCGCGACCCGGCCCCCGCTGCACGCACCCGACCTGGCCGACACGGTCGTCCACGTCGGCGACCTCGACTGTGTCACCGGCTGCCGCCGGCTGGCCGCGACCGAGGCGATCCTCGCCGGGGGGCTCCTCCGGCGCGGTCGTCAGCGCCCTCGACAGCCTGCGCCACGCCATCCCGGACGGCTCCACCTGCGCGATCGTCCTGCCCGACCGCGGCGAGCGCTACCTCAGCACGATCTACAACGACGCCTGGGTCTTGGAGAACTTCGGCCGGATCCCCCGGCCGCACGCGGTTCAGGAGAGCCAGTCGGCGTAGCGGGTGGGGGCGAGGTGGGCGTTCTTGTCCGTGAGGACGTCCCCCTTGACGGCGGCGAACATGCCGGCGGTGGGATCGGTGACGACGGTGCGGCCGTCGGACTTGTGGGACAGGGTGATCCGGCCCAGCTCGTCCAGGGTGAAGACCTCGGGTCCGCCGATGTTGCGGATGCCCCCCAGCGGGGCACCCGCGGCGACTTCCGCCACCGCGTCGGCCACGTCCTTGGCGGCGATCGGCTGGATCGGCGTGGGAGGCAGCCGGACGGTGTCGCCGTCGGTGGTCCAGGACATGGTCGCGTCCATGAATTCCATGAACTGCGTCGCGCGGACGATCGAGTAAGGGATCGCTCCGGCCGCGAGGATGTCCTCCTGGAGCACCTTGGCCTTGTAGTAGTCCAGCTCGGGGACCTTGTCCACGCCGACGATCGAGAGGATGACGAAGTGCCGGATACCACCCTTCCGGCCCGCGGCCAGAAGATTGTCCATCGAGGTCTGGAAGAAGGCGAGGGAGTCTTTGTCGAAGGTGGGGGAGTTCGTCAGGCTCACGAGGACGTCGGCCCCCGCCACCGCCTCGTCCAGTCCCTTGCCGGTGATGACGTCGACTCCGGTGGACTGTGA	MLTAEPGILSTIGATPLVELVRLFPDSPIRVFAKLEGFNPAGSIKDRPALSMLEDRIRRGDLVPGESVVVESSSGNLGIGLAQVCRYYGLRFICVVDPRANKQNIDIMRALGAEVEMVTEPDRETGDYLPARVARVRELARTVPGAYWPDQYGNTLNALAHRTTMREIHEALPGGLDYLICSASSCGTLRGCAEYIRAHRLPVKIVAVDALGSAIFDPSPPAVPRLLPGHGAATRPPLHAPDLADTVVHVGDLDCVTGCRRLAATEAILAGGLLRRGRQRPRQPAPRHPGRLHLRDRPARPRRALPQHDLQRRLGLGELRPDPPAARGSGEPVGVAGGGEVGVLVREDVPLDGGEHAGGGIGDDGAAVGLVGQGDPAQLVQGEDLGSADVADAPQRGTRGDFRHRVGHVLGGDRLDRRGRQPDGVAVGGPGHGRVHEFHELRRADDRVRDRSGREDVLLEHLGLVVVQLGDLVHADDREDDEVPDTTLPARGQKIVHRGLEEGEGVFVEGGGVRQAHEDVGPRHRLVQSLAGDDVDSGGL	MKKDSKSKEMIQSEKRGSTRLLMMVLSLSVLVGAITADLVNPVLPLISKDLEASKSQVSWIVSGIALVLAIGVPIYGRISDFFELRKLYIFAIMILASGSLLCAIAPNLPLLVLGRMVQGAGMSAIPVLSIIAISKVFPQGKRGGALGIIAGSIGVGTAAGPIFGGVVGQYLGWNALFWFTFLLAIMIVIGAYYALPTIKPAESVGSNKNFDFIGGLFLGLTVGLLLFGITQGETSGFSSFSSLTSLIGSVVALVGFIWRIVTAENPFVPPVLFNNKDYVNTVIIAFFSMFAYFAVLVFVPLLVVEVNGLSSGQAGMILLPGGVAVAILSPFVGRLSDRFGDKRLIITGMTLMGLSTLFLSTYASGASPLLVSVGVLGVGIAFAFTNSPANNAAVSALDADKVGVGMGIFQGALYLGAGTGAGMIGALLSARRDATEPINPLYILDAMSYSDAFLAATGAILIALIAGLGLKKRG	113.68	gnl|BL_ORD_ID|835|hsp_num:0	907			204	261	chloramphenicol; florfenicol
BGC0001002.1|Jawsamycin_14 # 15867 # 16079 # -1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0001002.1|Jawsamycin_14 	15867	16079	-	Loose	550	25.7942	OXA-266	32.5	3001722	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGAACCCGTTCGACGACACCGACGCGACGTTCCTCGTCCTGACCAACGCGGAGGGCCAGCACTCGCTCTGGCCCGCCTTCGCCGAGGTTCCCGCCGGCTGGACCGTGGCGTTCGGCGAGGACACCCACGCGGCCTGCGTGGAGCACATCGAGGCGAACTGGACCGACATGCGGCCCAAGAGCCTCGCCGAGCTGACGGACGCGCAGTGCTGA	MNPFDDTDATFLVLTNAEGQHSLWPAFAEVPAGWTVAFGEDTHAACVEHIEANWTDMRPKSLAELTDAQC	MRKKFKVALLCSSLCLSLGLVACHSLNSELQIAEQQKQQQKISKLFVNAKTEGVFVTYDGQKIHEYGNALNRAQTSYIPASTFKMLNALIGIQHHKTTPNEVFKWNGEKRRFKSWEKDLTLTEAIQASAVPIYQELARRIGLDLMASEVKRIGFGNSDIGNQVDNFWLVGPLKITPIQEVRFTYALANEQLAFDIPVQQQVKQMLLVDQMNGTKVYAKSGWGMDVEPQVGWWTGWVEQPNGKVTAFSLNMEMNKTEHVEARKTIVYEALQQLGLI	25.45	gnl|BL_ORD_ID|2366|hsp_num:0	3433			669	789	cloxacillin; oxacillin; cefalotin
BGC0001002.1|Jawsamycin_15 # 16076 # 25111 # -1 # ID=1_15;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.758	BGC0001002.1|Jawsamycin_15 	16076	25111	-	Loose	1000	134.035	almE	31.54	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	TTGTCGTTCGCGCAGCAGCGGCTGTGGTTCCTCCACAAGCTGGAGGGACCCGGCGCCACGCACAACCTTCCCTTCGCGCTACGGCTGACGGGAGAACTGGACACCCCGGCCCTGGAGGAGGCCCTCCGCGATGTGATCGGCCGGCACGAGAGCCTGCGCACCGTCTTCCCCGAGACCGAGGGCGTTCCCCAGCAGCTGGTCCTGGACCCGGTCGAGGCATGGACCGGCATGAAGGTCGTGCCGGTCTCCGAGGACGGCCTGGCCGCCGAGAGCGAGGCCGCGGCGCGGTACGCGTTCGACCTGTCCTGCGAAGCGCCCCTGCGGGCGACGCTGCTGCGGCTGTCGGAGCGGCAGCACGTCCTCGTCGTCACCCTGCACCGGATCGCCGGCGACGGCTGGTCGCTGGGCCCCCTGGCCCGCGACCTGTCGACGGCTTACGCGGCCCGGCGCGAGGGCGCGGCACCGGACTGGGCCGAACTTCCCCTGCGGTACACGGACTACACCCTGTGGCAGCGCGAGCTGCTCGGCGCCGGCGACGACCCCGGCGGCCTGTCGGCGCGGCAGAGCGCCTACTGGCGGCAGGCGCTGGACGGCGCCCCGGAGGAGCTGGCGCTGCCCCACGACCGGCCGCGCCCCGCCGTCGCCTCCTACCGGGGCGGGCACGTGCCCTTCGCGCTCGGCCCCGAGCTGCACGCCGGTCTGCGGCGCGTCGCCCGCGAGCACGGCACGACGCTGTTCCTGGTCCTCCAGGCCGGCCTCGCCGCCATGCTGTCCCGCATGGGCGCCGGGGAGGACGTCCCCGTCGGCTTCGACGTGGCCGGGCGGCCGGACGAGGCCCTCGACGACCTCGTCGGCCTCTTCGCCAACACCCTGGTCCTGCGCACCGACGTCTCCGGCGACCCCACGTTCACCGAGCTGCTCGGCCGGGTACGGGAACGCGCCCAGGAGGCGTACGGGCACCAGGACGTGCCCTACGAGCGCCTGGTCGCGGCCCTCGCCCCGGCCCCCTCCGCCGCCCGCCACCCCCTCTTCCAGGTGGCGCTGCTGCTCCGGCACCAGCAGGCCGAGTTCTCCTTCCCCGGCCTGCGGACCCGCCAGGAGCGGCCGGGCACCGGCACCTGCCGCTTCGACCTGTCCTTCTCCCTGGCCGAGCGGCTGGGTGAAGACGGCACGCCGGCCGGCCTGGACGGCTCCCTGGAGTACGCCGCCGAACTCTTCGACCACCCGACGGCCGCGGCACTGGCCGCCCGCCTGACGCGGGTCCTGGAACAGGCCGTGGCCGAGCCGGGCACACCCGTGGGCCGCCTGGAGGTGCTGTCCGCGCGGGAGCGCCACGACGTCCTGGAAGGCTGGAACGACACCGCCCGCGAGGGCGGCGTGGGCGACATCGTGGAGTGCGTACGCGAACTCGCCGAGGCCCGCCCCGACCGCATCGCCGTCGTGGACGGCGCGGGCGAGGTCAGCTACGCGGCCCTGGCCGCGCGGGCCGCCGGTGTGACGGCCGGGCTGAGGGAACTCCCCGAGTGGGGGCGCGGTCAGGTGGCCGGCCTGCTGGGCGGGCCCGGCACCGGCTTCGTCGCGGGCGTCCTCGGCGTGCTGGGCGCCGCGGGCGCGTTCGTCCCGCTGGACCCCGCGGCCCCCGCCGGCCGCTCCGCGGGCGTCGTCGCCGACGGCGGCGTGCGCGTCCTGCTGGTGGAGGAGGGGCTGGAGCCCCTGGCCGCGCGGATCGTGGCCGAGGCCGGCACCGCCATCACCGTGCTGCCGCTGCGCACCGCTGCCGCCGACTCGCCGCGCCCCTGGCCGGTGGCCCCGGCCTCCCCGCTCGACCTCGCCTACGTGATCTTCACCTCCGGTTCGACCGGCCGCCCCAAGGGCGCCATGGTCCACCGGGGAGGCATGGCCAACCACCTCTCCGCGAAGGTCGACGACCTGAAGCTGACCGCCGAGGACATCGTCGTCCAGAACGCCCCCCTCACCTTCGACGTCGCCGTCTGGCAGATGCTCGCCCCGCTGGCCGTCGGCGGCCGCGCCCGCATCGTCGACCACACCACCGCCGCCGACCCCGAAGCCCTCTTCGGCGTCGTGGAGGACGAGGACGTCACCGTCCTGGAAGTCGTCCCCTCCCTCCTGCGCACCGCCCTCGACGCCTGGGACGCGGGCCTGCGCGCCCCCCAACCGGCCGCGCTCCGCTGGCTGATGGTCACCGGCGAGGAACTCCCGCCCGAGCTGTGCGACCGCTGGTTCACCCGCTACCCGGACGTCCCCGTCGTCAACGCCTACGGCCCCACCGAGTGCTCGGACGACGTGACCCACGCCGTCCTCACCGGCCCCGTCACCGGCGCCCGGACGACCCCCATCGGCAAACCCGTGCGCAACACTCGCCTCTACGTCCTCGACGAGGTGCTGCGCCCGGTGCCCGTCGGCGTTCCCGGCGAGCTGTACGTCGCCGGGCGCGGCGTCGGCCGCGGCTACGTCGCCGACCCGGTGCGCACCGCCTCCGTGTTCGTCGCCGACCCCTACGCCCCCGCCGCCGGCGAGCGCATGTACCGCACCGGAGACCAGGTGCGGCGGCGGGCCGACGGGCAGCTGGAGTTCCTCGGCCGCCGCGACTTCCAGATCAAGGTCCGCGGCCACCGCGTCGAACTCGGCGAGATCGAGGCCGCCCTGCGCGCCGCGCCCGGCGTCACCGGCGCCGCCGCCTCCCTCGCCCACGACCCCGCCGGACGGCCCCAGCTGTGCGGCTACGTCACCGGCGACACCGACCCGGCGGCCGTCCGCGCCCACGTGACCGGCCTGCTGCCCGGCTACATGGTCCCCGCCGTCGTGACGGTCCTGCCCGCCCTGCCGCTGACCGCGCACGGCAAGACCGACCGCAAGGCCCTGCCCGCCCCCGACCTCACCGCCGTCACCGCCACCGCCTCCCGGCCCCCGCGCACCGCGGCCGAGGAGCTGCTGTGCGGCCTCTTCGCCGAGATCCTCGGCCTCGATGCCGTCGGCGCCGACGACGGCTTCTTCGACCTCGGCGGCCACTCGCTGCTGGCCACCCGGCTCGCCTCCCGCGTCCGCACCGCCTTCGGCGCCGAACTGCCCGTACGGGACGTCTTCGAGGCACCCACCCCCGCCGGGCTGGCCCTCCGCCTGGACGCCGCCGCGGCAGCGCGCCCCGCACTGGCCCGCCGGACCCGCCCCGAGCCGGTCCCGCTGTCGTACGCGCAGCAGCGGCTGTGGTTCCTCCACAAGCTGGAGGGCCCCGGCGCCACCTACAACATGCCCGTGTCCGTACGGCTGTCGGGCGAACTGGACGTCCCCGCCCTGGAGGCGGCCCTGTGCGATGTGATCGGCCGGCACGAGAGCCTGCGCACCGTCTTCCCCGAGACCGCGGGCGTCCCCCGGCAACTGGTGCTCGACGCGGCCGAGGCATGGCCCGGCCTCACCGCCGTGCCCGTCGCCGAGGACCGCCTGGCGGAGGAGATCGCGGCCGCGGCCCGGCACGGATTCGACCTGTCCTGCGAACCCCCGGTCCGCACCACCCTGCTGCGGGTCTCCGAGCGGGAGCACGTCCTGCTGTTCGTCCTGCACCACGTCGCCGGCGACGGCTGGTCCCTCGGCCCGCTGACGCGCGACCTGTCCGAGGCCTACCGCGCCCGGCACGCCGGGCACGGCCCCGGCTGGGCGGAACTGCCCGTCCAGTACGCCGACTACACGCTGTGGCAGCGCGAACTGCTGGGCACCGAGGACGACCCGGACAGCGTGATGTCCCGCCAGGTGACCTACTGGCGCGAGGAACTGGCCGGCGCCCCCGAGGAGCTCGCCCTGCCCTACGACCGGCCGCGGCCCGCCGTCGCCTCCCACCGGGGCGGCTACGTACCGTTCGAGGTGGGCCCCGAGCTCCACGAGGGCCTGCACCGGGTGGCACGCGAGCACGGCGCCACCCCGTTCATGGTGCTCCAGGCCGCCCTGGCCGCCCTGCTCTCCCGGCTCGGCGCCGGCGAGGACGTCCCCGTCGGCTTCGGCGTCGCCGGCCGCCTGGACGACGCGCTCGACGGGCTGGTGGGCTTCTTCGTCAACACCCTCGTCCTGCGCGCCGACCTCTCCGGCGACCCGACGTTCGCCGGACTCCTCGGCCGCGTCCGCCGCTCGGCGCTGGCCGCCTACGCTCACCAGGACGTGCCGTTCGAGCACCTCGTCGAGACCCTCGCCCCGGCCCGCTCGGCCGCCCGCCACCCGCTCTTCCAGGTCGCCCTCGTCCTCCAGAACAACCGGCGCGGCGAGATCGACCTGCCCGGCCTGCGCACCCGCATGGAATGGGCGGGCACCGGCACCTCCCGGCTCGACCTCTTCTTCTCCCTGGACGAACGGGAGGACGCCGCGGGCCGCCCGGTGGGTCTGGACGGCGCCGTGGAGTACGCCACCGAACTGTTCGACCGCGCGACGGTCGAAGGCCTCGTAGGCGGCCTCCTGCGGGTGCTGGAGCAGGCCGTCACCGACCCCGGCATCCCCGTGGAGCGGCTGGACCCGCTCTCCGCACGGGGCCGCCACGACGTGCTCGACGGCTGGAACGACACCGCCGTGGAGCTGTCCGGCCCGGCGACCCTGCCCGCCCTCTTCGAGGCCCGCGCCGCCCGTACACCCGCCGCGGCGGCCATTGACCACGGCGGCGAGGAGACCACCTACGCCGAACTGGACACCCGCGCCGGCCGGCTGGCACGGCAACTGACCGCCGCCGGCGTGGGCCCCGGCGACCTCGTGGCACTCTCCCTGCCCCGCTCCGCCGAACTGGTCGTCGCGGTCCTGGGCGTGCTCAAAGCCGGCGCCGCCTACCTGCCCGTGGACCCCGGATACCCGGACGCGCGGATCCGCTTCATGCTCTCCGACGCCGCCCCGAAGCTGCTGCTGACGGACGGCCCGACCGCGAAGGCGCTGCCCGGGACCGGCGTGGAGCACCGGCTCCTCGACGACCCGGCGACCGCCGCGGCACCGGAGGCGCCCGCACGGCCCCCGCGCCCGGACGACCCGGCGTACGTCATCTACACCTCCGGCTCCACCGGCCGCCCCAAGGGCGTCGTCGTCCCGCACAAGGGCCTGCCCGCCCTCGCCGCCGCACAGGCCGCCGGCCTCGCGGCCGACGCCACGAGCCGGGTGCTCCAGCTCTCCTCGCCCAGCTTCGACGCCTCCGTCTGGGACCTCCTCATGGCCCTGGCCGCGGGCGGCACCCTGGTCCTGCCCGACACCGACGGGCCGCTGACCGGCGAAGCGCTCGCCGAGACCCTCGCGGCACGGAACGTCACCCACCTGACGATCACCCCCACGGCCCTGGAGGCCGTACCCCCGGGCGCCGAGTCCGCGCTCGCCGCCCTGCGCACCGTCGTGACCGCGGGCGAGACCTGCCCCGCACCCCTCGTCGAGCGGTGGGCACCCAGGCGCCGGATGGTCAACGCCTACGGGCCGACCGAGGCCACCGTGTGCGCCACCATGAGCGACGCCCTCTCGGCGGAGGCCGTGGGCACCGGACCCGTGCCCATCGGCCGCCCGGTCACCAACGCCCGCGTGTACGTCCTGGACGCCCGGCTGCGCCCGGTGCCGCCGGGCGTGACCGGCGACCTGTACCTCGCGGGCCCCGGCCTCGCCCACGGCTACCTGAACCGGCCGGGCCTGACGGCGGAACGCTTCGTCGCCTGCCCGTTCGGCGCCCCCGGCGAGCGGATGTACCGCACCGGCGACGTCGCGGCCTGGACGCCCGGCGGACAGCTGGTCTTCCGGGGCCGGGCGGACGAGCAGGTGAAGGTCCGCGGCCACCGCGTCGAGCTCGGCGAGGTCGAAGCCCGCCTCCTGGAACACCCCTCGGTGGGCCGGGCCGCGGTCGTCGCCCGCGAGGAGACCCCCGGCGACGTGCGCCTGGTCGCCTACGTCGTCCCCACCTCCGGTACGGACGCCCCCGGCACGGACGCCTCCGGCGGGGAACTCGTCGACGAATGGCGCGACATCCACGACCAGGTGTACGCGGCCTCCGGGCCGGCGCCCTGGGGCGAGGACTTCCGCGGCTGGGACAGCACCTACGACGGCGAGCCGATCCCGCTGGAGCAGATGCGCGAGTGGCGGGACGCGACGGTGGCCCGGATCGCCGAGCTGCGGCCGCGCCGCGTCCTGGAGATCGGCGTCGGCGCCGGACTGCTGCTGTCCCGGCTGGCCGGGCACTGCGAGACGTACTGGGGCACCGACTTCTCCCCGGCCGCGGTGGCGAAGCTGACCGCCCACGTCGCCGCCGACCCGGAGCTCGCCGCGAAGGTCGAACTGCGCTGCCTGCCCGCCCACGACGCCGACGGACTGCCGGCCGGCTTCTTCGACACCATCGTGATCAACTCCGTCGCGCAGTACTTCCCCGACGCCGGCTACCTCTCCCAGGTCCTCGGCACGTGCCTCGGCCTGCTCGCACCGGGCGGCACCGTGTACGTCGGCGACGTACGCAACCTGCGGACACGGCGCGCCCTCCAGGCGGGCGTGGCAAGCCACCGCCCGGCCGACGGCACATCCAGTGCGGACGACACCTCCGGGCAGGACGAGACCGGCACGGCGGACGCGCTCGACCACGCGCTCGACGCCGAGACGGAGCTCCTGGTGGCCCCGGAGTTCTTCACCGCCCTGGCCGCCGCCGACGACCGCGTCACCGGCGTCGACATCCGCCTCAAGCGCGGCCTGCACCACAACGAGCTCACCCGCCACCGCTACGAGGCCGTGCTCCGCAAGACCTCCGGCCCGGACACCGAAGCGGCCGCGCCCCTCCTGCCGGTCGACGGCCTGGAGGAGCTCCCCTGGGAGCGGCTCGCCACCAGTGGTACGGGAGCCGACGGCATCGCCGCCCTCGCGGCCCGGCTGGCCACCGGCGGCACCGGACTGCGGATCACCGGCGTGCCCAACGGCCGTCTGCTCGGCGAGTTCTCAGCCCTGGCCGCACTCGGCCGCCCCGGCGACGCACCCGAGCCCCCCGTCCAGGGCCCGGGCGCCGACCCGGAGGCGCTCTGCCGGCTCGGCGAAGCCCTCGGCCTGCGGCCCGTCGCCACTTGGTCGCCCGCCCGGCACGACACCTTCGACATCGCCTTCCTGCCCGCCGGCACCACCGGCCCCGTGGCCGCTTACACCCACCCGGAGGCCGACCCCGACCCCGCCGCCCATGTCAGCACGCCGCTGGGCGCCCGCGGCCACCGGGAGCCCGGCGCGGGCACCTCCGCCGCAGCCGCCCTGAAGCGGCACCTCGCCGAGGTCCTGCCCGCGTTCATGGTCCCGTCCGCCTACGTCACCCTCCACCAGCTGCCCATGACGGCCAACGGCAAGCTGGACCGCAAGGCCCTGCCCGAACCCGTCCTCGCCACCGCGCCGGCCGGACGCGCCGCGCGCACCCCCGCCGAGGAACTGCTCCGCGGCGCGTTCGCCGACGTCCTCGGCCTGGCCGCCGTGGGCGCCGACGACAACTTCTTCGACCTCGGCGGACACTCGCTGCTCGCCACCCGCCTGGTCAGCCGGATCCGGTCGGCGCTGGGCACGGAGCTCAGCCTCCGCGACCTTTTCGGCGCCCCCACCGCCGCCGAACTGGCCGCACTGGTCGCGGAACGCCGGTCGGAGGCGGGCCGCCCGGCACCGGCCCCGTACGAGCGCCCCGAGCGCATCCCGCTCTCCCCGGCCCAGGACCGCACCCTGCGGATCGGACTGGGCAACGCATCGGCCTCCAGCGCCCTGAAGAACATGCCGCTCGCCCTCCGGCTCACCGGCGACACCGACCGCGCGGCCCTGGAAGCCGCCCTCACGGACGTCGTCCACCGGCACGAGGCGCTGCGTACCCTCTTCCCCGGCCCCGACGGCGACCGCCACCAGCGCGTCCTCGCACCCGAGGACGCCCGCGTCACCCTGCCGGTCGTCCCCGCCACCGAGGCCGAGCTGGCCGACCGGGTCCGCGACGCCGCCCACCACGAATTCGACCTGCGGACGGAACCGCCCTTCCGGGCCGTGCTGTTCGAGGCCGCCGAGCGCGAACACGTCCTCGTCCTCGTATGGCACCACATCGCCGGTGACGGCTGGTCGGTCGGCGTGCTCCTGCACGACCTCGCCACCGCGTACGCCGCCCGGCGCTCGGGCGACGAGCCCGGCCGGGAGCCGCTCGCCCTCCAGTACGCCGACTACACCCTGTGGCTGGCGGACCTGCTGGGCGACGCCTCCGACCCGGAGAGTCTCGCCGCGCGCGGGCACGCCTTCTGGAGCGAGACGCTGGCGGACCTGCCCGTGGAGGTGACCCCGCCCCTGGACCGGCCACGGCCGGACCACCCCACCCACCGGGGCGCGACCCTCCCCTTCGAGATCGCCCCGGACGTCCACCGCGGCCTCCGGGAACTGGCCGCACGGCAGGACACCACCTTGTTCATGGTCCTGCACACCGCCCTCGCCGCCGCCCTGACCCTGACCGGCGCCGGCACCGACATCCCCGTCGGCACCCCCATCGCGGGCCGGGTGGACGAAGGCCTCGACGACCTCGTCGGCCTCTTCACCAACTACCTCGTCCTGCGCCTGGACACCTCGGGCGACCCCGCCTTCACGGACCTCCTCCGCCGGGCCAGGGACGCCGACTTTGCCGCCTACGAGCACCAGGAGTACCCCTTCACCGGCATGGTCGACGCCTGCGACCCGCCCCGGCACCCGGGGCGCCACCCGCTGTTCCAGACCATGCTCGTCCTGCAGAACTACGCCGGAACCGCCCTGGACATGCCCGGGCTGGCGGTCGAGCCGTTCCCCGTGGACCACGCGTCGGCCCGCATCGACTTCTCCCTCCTGCTGACCGACGCGCCCGGCGCCGACGGCATGAGCGGGCACGTCGAGTACGCCGACGAGCTGTTCGACCGCGAGACCGTCGAACGCTTCTGCGCCGTCCTCACCGACGTCCTGTCGGCCGCCTGTGACCGCCCCGGCCTCCCCATCGGCCGGACGACCCCGGCCCCCGCGCCCGCCGGGCGCCCCCTGACCGCCGCGACCTCCGAAGGAGACCAGCTGTGA	LSFAQQRLWFLHKLEGPGATHNLPFALRLTGELDTPALEEALRDVIGRHESLRTVFPETEGVPQQLVLDPVEAWTGMKVVPVSEDGLAAESEAAARYAFDLSCEAPLRATLLRLSERQHVLVVTLHRIAGDGWSLGPLARDLSTAYAARREGAAPDWAELPLRYTDYTLWQRELLGAGDDPGGLSARQSAYWRQALDGAPEELALPHDRPRPAVASYRGGHVPFALGPELHAGLRRVAREHGTTLFLVLQAGLAAMLSRMGAGEDVPVGFDVAGRPDEALDDLVGLFANTLVLRTDVSGDPTFTELLGRVRERAQEAYGHQDVPYERLVAALAPAPSAARHPLFQVALLLRHQQAEFSFPGLRTRQERPGTGTCRFDLSFSLAERLGEDGTPAGLDGSLEYAAELFDHPTAAALAARLTRVLEQAVAEPGTPVGRLEVLSARERHDVLEGWNDTAREGGVGDIVECVRELAEARPDRIAVVDGAGEVSYAALAARAAGVTAGLRELPEWGRGQVAGLLGGPGTGFVAGVLGVLGAAGAFVPLDPAAPAGRSAGVVADGGVRVLLVEEGLEPLAARIVAEAGTAITVLPLRTAAADSPRPWPVAPASPLDLAYVIFTSGSTGRPKGAMVHRGGMANHLSAKVDDLKLTAEDIVVQNAPLTFDVAVWQMLAPLAVGGRARIVDHTTAADPEALFGVVEDEDVTVLEVVPSLLRTALDAWDAGLRAPQPAALRWLMVTGEELPPELCDRWFTRYPDVPVVNAYGPTECSDDVTHAVLTGPVTGARTTPIGKPVRNTRLYVLDEVLRPVPVGVPGELYVAGRGVGRGYVADPVRTASVFVADPYAPAAGERMYRTGDQVRRRADGQLEFLGRRDFQIKVRGHRVELGEIEAALRAAPGVTGAAASLAHDPAGRPQLCGYVTGDTDPAAVRAHVTGLLPGYMVPAVVTVLPALPLTAHGKTDRKALPAPDLTAVTATASRPPRTAAEELLCGLFAEILGLDAVGADDGFFDLGGHSLLATRLASRVRTAFGAELPVRDVFEAPTPAGLALRLDAAAAARPALARRTRPEPVPLSYAQQRLWFLHKLEGPGATYNMPVSVRLSGELDVPALEAALCDVIGRHESLRTVFPETAGVPRQLVLDAAEAWPGLTAVPVAEDRLAEEIAAAARHGFDLSCEPPVRTTLLRVSEREHVLLFVLHHVAGDGWSLGPLTRDLSEAYRARHAGHGPGWAELPVQYADYTLWQRELLGTEDDPDSVMSRQVTYWREELAGAPEELALPYDRPRPAVASHRGGYVPFEVGPELHEGLHRVAREHGATPFMVLQAALAALLSRLGAGEDVPVGFGVAGRLDDALDGLVGFFVNTLVLRADLSGDPTFAGLLGRVRRSALAAYAHQDVPFEHLVETLAPARSAARHPLFQVALVLQNNRRGEIDLPGLRTRMEWAGTGTSRLDLFFSLDEREDAAGRPVGLDGAVEYATELFDRATVEGLVGGLLRVLEQAVTDPGIPVERLDPLSARGRHDVLDGWNDTAVELSGPATLPALFEARAARTPAAAAIDHGGEETTYAELDTRAGRLARQLTAAGVGPGDLVALSLPRSAELVVAVLGVLKAGAAYLPVDPGYPDARIRFMLSDAAPKLLLTDGPTAKALPGTGVEHRLLDDPATAAAPEAPARPPRPDDPAYVIYTSGSTGRPKGVVVPHKGLPALAAAQAAGLAADATSRVLQLSSPSFDASVWDLLMALAAGGTLVLPDTDGPLTGEALAETLAARNVTHLTITPTALEAVPPGAESALAALRTVVTAGETCPAPLVERWAPRRRMVNAYGPTEATVCATMSDALSAEAVGTGPVPIGRPVTNARVYVLDARLRPVPPGVTGDLYLAGPGLAHGYLNRPGLTAERFVACPFGAPGERMYRTGDVAAWTPGGQLVFRGRADEQVKVRGHRVELGEVEARLLEHPSVGRAAVVAREETPGDVRLVAYVVPTSGTDAPGTDASGGELVDEWRDIHDQVYAASGPAPWGEDFRGWDSTYDGEPIPLEQMREWRDATVARIAELRPRRVLEIGVGAGLLLSRLAGHCETYWGTDFSPAAVAKLTAHVAADPELAAKVELRCLPAHDADGLPAGFFDTIVINSVAQYFPDAGYLSQVLGTCLGLLAPGGTVYVGDVRNLRTRRALQAGVASHRPADGTSSADDTSGQDETGTADALDHALDAETELLVAPEFFTALAAADDRVTGVDIRLKRGLHHNELTRHRYEAVLRKTSGPDTEAAAPLLPVDGLEELPWERLATSGTGADGIAALAARLATGGTGLRITGVPNGRLLGEFSALAALGRPGDAPEPPVQGPGADPEALCRLGEALGLRPVATWSPARHDTFDIAFLPAGTTGPVAAYTHPEADPDPAAHVSTPLGARGHREPGAGTSAAAALKRHLAEVLPAFMVPSAYVTLHQLPMTANGKLDRKALPEPVLATAPAGRAARTPAEELLRGAFADVLGLAAVGADDNFFDLGGHSLLATRLVSRIRSALGTELSLRDLFGAPTAAELAALVAERRSEAGRPAPAPYERPERIPLSPAQDRTLRIGLGNASASSALKNMPLALRLTGDTDRAALEAALTDVVHRHEALRTLFPGPDGDRHQRVLAPEDARVTLPVVPATEAELADRVRDAAHHEFDLRTEPPFRAVLFEAAEREHVLVLVWHHIAGDGWSVGVLLHDLATAYAARRSGDEPGREPLALQYADYTLWLADLLGDASDPESLAARGHAFWSETLADLPVEVTPPLDRPRPDHPTHRGATLPFEIAPDVHRGLRELAARQDTTLFMVLHTALAAALTLTGAGTDIPVGTPIAGRVDEGLDDLVGLFTNYLVLRLDTSGDPAFTDLLRRARDADFAAYEHQEYPFTGMVDACDPPRHPGRHPLFQTMLVLQNYAGTALDMPGLAVEPFPVDHASARIDFSLLLTDAPGADGMSGHVEYADELFDRETVERFCAVLTDVLSAACDRPGLPIGRTTPAPAPAGRPLTAATSEGDQL	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	541.55	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1629	colistin A; colistin B
